PTEN stability is not affected by Nedd4-1. (A) PTEN levels are unchanged in the absence (knockout) of Nedd4-1. Levels of PTEN in MEFs and heart tissue from Nedd4-1+/+, Nedd4-1+/−trap, and Nedd4-1−/−trap embryos (Top), and MEFs from Nedd4-1+/+ and Nedd4-1−/−exons9,10 embryos (Bottom) were analyzed by immunoblotting. Expression of Nedd4-1 in embryonic hearts of Nedd4-1+/+ and Nedd4-1+/−trap (but not Nedd4-1−/−trap) mice is depicted in the Middle. (B and C) PTEN levels are unchanged by knockdown of Nedd4-1. (B) HEK293T cells were either not transfected or were transfected individually with three different shRNAmir (in pGIPZ) directed toward the human Nedd4-1 sequence or pGIPZ plasmid containing a nonsilencing control. After 72 h, cells were lysed, and levels of Nedd4-1, PTEN, and actin were determined by immunoblotting with their respective antibodies. Endogenous levels of Nedd4-1 were reduced 62%, 70%, and 71% for shRNA (), shRNA () and shRNA (), respectively (average of n = 5, relative to cells transfected with nonsilencing control). Average PTEN levels in these experiments remained close to 100% for each of the knockdown constructs [93%, 90%, and 97% for shRNA (), shRNA () and shRNA (), respectively (n = 5, relative to nonsilencing control)]. Actin levels remained constant as well (99%, 105%, and 102% compared with nonsilencing control, respectively). The experiment shown is a representative of three independent experiments, each performed in duplicate. (C) WT MEFs (Nedd4-1+/+,exons9,10) were transfected with shRNA directed against mouse Nedd4-1. Cells were then analyzed for the extent of Nedd4-1 knockdown and levels of PTEN and actin, as described above. Average Nedd4-1 knockdown was 56% (n = 4), whereas actin levels remained unchanged. (D) Reconstitution of Nedd4-1 in Nedd4-1−/−exons9,10 MEFs does not alter PTEN levels. Nedd4-1−/−exons9,10 MEFs were transfected with GFP-Nedd4-1, and 24 h later cells were analyzed for expression of Nedd4-1 by using anti-GFP antibodies, and for the levels of PTEN and actin, as described above.